Delivery Order SPE2DB20D1047-SPE2DB25FF83Z
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram units, with a contract ceiling value of $1,242.98. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a delivery order valued at $5,568.13 to AmerisourceBergen Drug Corp for Zoryve 0.3% Foam 60GM on September 10, 2025, with completion targeted for September 11, 2025. This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the...
- The Defense Logistics Agency awarded a $2,288.33 delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ZORYVE is a topical dermatological treatment used primarily for inflammatory skin conditions, and this delivery order reflects...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.57 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM on August 27, 2025, with completion scheduled for August 28, 2025. This competitive award, issued under a firm fixed-price contract with no set-aside designation, represents a single delivery order for a topical pharmaceutical product. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency awarded a $23,646.57 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with a completion date of September 12, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $1,846.66 to supply Zoryve 0.3% Foam in 60-gram quantities. The contract was competitively awarded without set-aside designation and carries a completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,161.02 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ZORYVE 0.3% Foam 60GM, a topical dermatological medication. This firm fixed price delivery order, valued at $1,158.98, represents a non-set-aside competitive award with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,870.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,092.43 to supply ZORYVE 0.3% Foam in 60-gram units. This contract represents a child delivery order under a larger indefinite delivery contract vehicle, utilizing firm fixed-price pricing with no set-aside designation. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania....